Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04629664 · ClinicalTrials.gov registry record · Phase 1
FX-322 in Adults With Severe Sensorineural Hearing Loss
A Phase 1 study of Hearing Loss, Sensorineural and Noise-induced Hearing Loss, sponsored by Frequency Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
- 7
- Study locations
NCT04629664 is a Phase 1 study of Hearing Loss, Sensorineural and Noise-induced Hearing Loss that has completed, run by Frequency Therapeutics. The registered enrollment target is 31 participants, below the 785-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (96% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT04629664, a Phase 1 study of Hearing Loss, Sensorineural and Noise-induced Hearing Loss, has completed, sponsored by Frequency Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a Phase 1b, prospective, randomized, double-blind, placebo-controlled, single-dose, multicenter, safety study of FX-322, administered by intratympanic injection, in adults with severe sensorineural hearing loss.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG FX-322
Study Locations (7)
Texas
- Clinical Trial Site - San Antonio #1 - San Antonio
- Clinical Trial Site - San Antonio #2 - San Antonio
Michigan
- Clinical Trial Site - Novi
Nebraska
- Clinical Trial Site - Omaha
New York
- Clinical Trial Site - Amherst
South Carolina
- Clinical Trial Site - Orangeburg
Virginia
- Clinical Trial Site - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2021-09-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04629664
The ClinicalTrials.gov registry entry for NCT04629664 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (96% lower). The listed sponsor is Frequency Therapeutics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04629664 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Texas, Michigan, Nebraska.
Frequently Asked Questions
What is clinical trial NCT04629664 about?
NCT04629664 is a clinical study titled "FX-322 in Adults With Severe Sensorineural Hearing Loss". This is a Phase 1b, prospective, randomized, double-blind, placebo-controlled, single-dose, multicenter, safety study of FX-322, administered by intratympanic injection, in adults with severe sensorineural hearing loss.
What is the current status of trial NCT04629664?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2020-11-02. Estimated completion is 2021-09-20.
What conditions does trial NCT04629664 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Noise-induced Hearing Loss, Sudden Hearing Loss.
What interventions are being tested in trial NCT04629664?
The interventions under investigation include: Placebo (OTHER), FX-322 (DRUG).
Who is sponsoring clinical trial NCT04629664?
This trial is sponsored by Frequency Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04629664 being conducted?
This trial has 7 study locations across Michigan, Nebraska, New York, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Barriers and Facilitators to OTC Hearing Aids Success
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Listening Effort in Cochlear Implant Users
RECRUITING · NA
-
Post-Market Clinical Investigation of the IotaSOFT Insertion System
RECRUITING
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.